While the biotech world chases billion-dollar IPOs, Geniphys is playing a different game entirely. With just 8 employees and $300K in revenue, this medical startup is building a foundation for regenerative medicine without the usual VC noise.

"They're not building a platform to get acquired—they're building a company to last."

The 33% organic traffic is surprisingly healthy for a medical startup this size. Most early-stage companies struggle to crack 20% organic. This suggests either strong word-of-mouth or a niche product with specific search intent. Their tech stack—Vue.js with Tailwind and Bootstrap—shows modern web development priorities, even if the site itself appears minimalist.

• Bootstrapped revenue model with $300K ARR from just 8 people
• Direct traffic dominates (42%), indicating strong referral/word-of-mouth
• Academic founder pedigree suggests deep IP moats
• Unconventional keyword strategy targeting non-branded search terms